Title

Regulatory Reactivity in FDA’s Approval of Aduhelm

Authors

Yaniv Heled
Ana Santos Rutschman
Liza Vertinsky

Document Type

Online Essay

Publication Date

7-6-2021

Description

A controversial approval of an Alzheimer’s treatment reveals a core weakness in oversight of agency discretion.

Keywords

Process, Health, Chevron, Effective Regulation, Judicial deference

Recommended Citation

Heled, Yaniv; Rutschman, Ana Santos; and Vertinsky, Liza, "Regulatory Reactivity in FDA’s Approval of Aduhelm" (2021). The Regulatory Review - Opinion. 184.
https://scholarship.law.upenn.edu/regreview-opinion/184